Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Therapeutic Vaccination + PegIFN in Entecavir-Treated Chronic Hepatitis B
NCT02097004Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2014
- Primary completion
- Jan 2018
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by Seoul National University Hospital. Started Apr 2014; status: completed.
02
Drugs
peginterferon alfa-2aHepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02097004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097004.